[Lys(B28), Pro(B29)]‐human insulin: Effect of injection time on postprandial glycemia

[1]  P. Meda,et al.  Insulin Gene Transcription Is Decreased Rapidly by Lowering Glucose Concentrations in Rat Islet Cells , 1994, Diabetes.

[2]  D. Howey,et al.  [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin , 1994, Diabetes.

[3]  D. Howey,et al.  Establishment of Time-Action Profiles for Regular and NPH Insulin Using Pharmacodynamic Modeling , 1994, Diabetes Care.

[4]  P. Cryer.  Hypoglycemia Unawareness in IDDM , 1993, Diabetes Care.

[5]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[6]  T. Danne,et al.  Effect of High Glucose on Type IV Collagen Production by Cultured Glomerular Epithelial, Endothelial, and Mesangial Cells , 1993, Diabetes.

[7]  L. Slieker,et al.  Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics. , 1993, Advances in experimental medicine and biology.

[8]  B H Frank,et al.  Altering the association properties of insulin by amino acid replacement. , 1992, Protein engineering.

[9]  R. DiMarchi,et al.  Human Insulin Analogs with Rapid Onset and Short Duration of Action , 1992 .

[10]  N. Fineberg,et al.  Presence of Insulin Autoantibodies as Regular Feature of Nondiabetic Repertoire of Immunity , 1991, Diabetes.

[11]  Irl B Hirsch,et al.  Intensive Insulin Therapy for Treatment of Type I Diabetes , 1990, Diabetes Care.

[12]  J. Hörnquist,et al.  Insulin-pen treatment, quality of life and metabolic control: retrospective intra-group evaluations. , 1990, Diabetes research and clinical practice.

[13]  R. Fisken,et al.  Treatment of insulin-dependent diabetes using an injection pen: control, problems and patient preferences. , 1989, Diabetes research.

[14]  H. Parving,et al.  Effect of multiple insulin injections with a pen injector on metabolic control and general well-being in insulin-dependent diabetes mellitus. , 1989, Diabetes research.

[15]  P. Salmon,et al.  A Randomized Trial of the Efficacy and Acceptability of a Pen Injector , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[16]  E. Kraegen,et al.  Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes , 1988, Diabetes.

[17]  B. Clarke,et al.  The Importance of the Time Interval Between Insulin Injection and Breakfast in Determining Postprandial Glycaemic Control—A Comparison Between Human and Porcine Insulin , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[18]  C. F. Merwe.  Blood glucose control and diabetic complications. , 1987, Annals of internal medicine.

[19]  R. Arakaki,et al.  The pharmacokinetics of subcutaneous regular insulin in type I diabetic patients: assessment using a glucose clamp technique. , 1986, The Journal of clinical endocrinology and metabolism.

[20]  P. Raskin,et al.  Blood glucose control and diabetic complications. , 1986, Annals of internal medicine.

[21]  L L Ng,et al.  Interval between insulin injection and eating in relation to blood glucose control in adult diabetics. , 1985, British medical journal.

[22]  B. Mills,et al.  Meal intolerance in type 1 diabetes mellitus: influence of time interval between insulin therapy and meal intake. , 1984, Journal of medicine.

[23]  M. Siperstein.  Diabetic microangiopathy and the control of blood glucose. , 1983, The New England journal of medicine.

[24]  N. White,et al.  Roles of site and timing of the morning insulin injection in type 1 diabetes. , 1983, Jornal de Pediatria.

[25]  G. Dimitriadis,et al.  Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus , 1983, Diabetes Care.

[26]  R. Unger.  Special Comment: Meticulous Control of Diabetes: Benefits, Risks, and Precautions , 1982, Diabetes.

[27]  V. Jörgens,et al.  Absorption Kinetics and Biologic Effects of Subcutaneously Injected Insulin Preparations , 1982, Diabetes Care.

[28]  J. Davidson,et al.  Factors Influencing the Absorption, Serum Insulin Concentration, and Blood Glucose Responses After Injections of Regular Insulin and Various Insulin Mixtures , 1981, Diabetes Care.

[29]  S. Fineberg,et al.  The Plasma Glucose Response of Normal Fasting Subjects to Neutral Regular and NPH Biosynthetic Human and Purified Pork Insulins , 1981, Diabetes Care.

[30]  M. Chou,et al.  Time-action characteristics of regular and NPH insulin in insulin-treated diabetics. , 1980, The Journal of clinical endocrinology and metabolism.

[31]  A. Kinmonth,et al.  Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children , 1980, British medical journal.

[32]  F. Service,et al.  Characteristics of Glycemic Stability , 1980, Diabetes Care.

[33]  P. Campbell,et al.  Enzyme changes in neonatal skeletal muscle: effect of thyroid deficiency. , 1978, The American journal of physiology.

[34]  D. Rodbard,et al.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. , 1978, The American journal of physiology.

[35]  J. Roth,et al.  Control of blood glucose and diabetic vascular disease. , 1977, The New England journal of medicine.

[36]  N. Freinkel,et al.  Control and Diabetes , 1976 .

[37]  C. Binder,et al.  The Absorption of an Acid and a Neutral Insulin Solution after Subcutaneous Injection into Different Regions in Diabetic Patients , 1967 .